PTEN and Inherited cancer-predisposing syndrome: CS/CS-like and BRRS are good models for hereditary cancer syndromes, where PTEN-informed clinical risk assessment results in gene-informed surveillance recommendations and clinical management of PTEN mutation positive patients [6].